{"id":"https://openalex.org/W4362546641","doi":"https://doi.org/10.1158/2326-6066.c.6549196.v1","title":"Data from Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression","display_name":"Data from Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362546641","doi":"https://doi.org/10.1158/2326-6066.c.6549196.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.c.6549196.v1","doi":"https://doi.org/10.1158/2326-6066.c.6549196.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2326-6066.c.6549196.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/2326-6066.c.6549196.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101493187","display_name":"Jing Liao","orcid":"https://orcid.org/0000-0002-9591-8070","observed_orcids":["https://orcid.org/0000-0002-9591-8070"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Liao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100530313","display_name":"Yan Luan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yan Luan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001598173","display_name":"Zhenhua Ren","orcid":"https://orcid.org/0000-0002-2560-5618","observed_orcids":["https://orcid.org/0000-0002-2560-5618"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhenhua Ren","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100411352","display_name":"Xiaojuan Liu","orcid":"https://orcid.org/0000-0002-5041-0548","observed_orcids":["https://orcid.org/0000-0002-5041-0548"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaojuan Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033303230","display_name":"Diyuan Xue","orcid":"https://orcid.org/0000-0002-8299-9895","observed_orcids":["https://orcid.org/0000-0002-8299-9895"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diyuan Xue","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101096491","display_name":"Hairong Xu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hairong Xu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005329825","display_name":"Zhichen Sun","orcid":"https://orcid.org/0000-0001-7837-8407","observed_orcids":["https://orcid.org/0000-0001-7837-8407"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhichen Sun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047294733","display_name":"Kaiting Yang","orcid":"https://orcid.org/0000-0001-9328-5655","observed_orcids":["https://orcid.org/0000-0001-9328-5655"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kaiting Yang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100729967","display_name":"Hua Peng","orcid":"https://orcid.org/0000-0003-3774-5033","observed_orcids":["https://orcid.org/0000-0003-3774-5033"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hua Peng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5035676180","display_name":"Yang\u2010Xin Fu","orcid":"https://orcid.org/0000-0001-8441-6617","observed_orcids":["https://orcid.org/0000-0001-8441-6617","https://orcid.org/0000-0002-4809-825X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yang-Xin Fu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.39480000734329224,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.39480000734329224,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.3386000096797943,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.2087000012397766,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.8190000057220459},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.8999999761581421},{"id":"https://openalex.org/keywords/cd8-tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating CD8+ T cells","score":0.8650000095367432},{"id":"https://openalex.org/keywords/antigen-presenting-cells","display_name":"antigen-presenting cells","score":0.8550000190734863},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.6439999938011169},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.7990000247955322},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.5899999737739563},{"id":"https://openalex.org/keywords/interferon-toxicity","display_name":"interferon toxicity","score":0.578000009059906},{"id":"https://openalex.org/keywords/syngeneic-mouse-model","display_name":"syngeneic mouse model","score":0.8379999995231628}],"concepts":[{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.6500718593597412},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6419569253921509},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.6317577958106995},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5718382596969604},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.565209686756134},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.529927670955658},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.4770909249782562},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.45078954100608826},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4362052381038666},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.427789568901062},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.41847944259643555},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.31730973720550537},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.27892786264419556},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25358492136001587},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.14953574538230896},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6066.c.6549196.v1","doi":"https://doi.org/10.1158/2326-6066.c.6549196.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2326-6066.c.6549196.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.c.6549196.v1","doi":"https://doi.org/10.1158/2326-6066.c.6549196.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2326-6066.c.6549196.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2618705717","https://openalex.org/W2042108891","https://openalex.org/W2305855934","https://openalex.org/W4361952469","https://openalex.org/W2563087865","https://openalex.org/W4313383434","https://openalex.org/W2055585595","https://openalex.org/W2557478274","https://openalex.org/W3014403824","https://openalex.org/W2983983259"],"abstract_inverted_index":{"Abstract":[0],"Anti-hCD20":[1],"is":[2,7],"a":[3,27,60],"therapeutic":[4],"mAb":[5],"that":[6,34,98,116],"clinically":[8],"used":[9],"to":[10,18,45,78,127],"treat":[11],"B-cell":[12,43,111,119],"lymphoma.":[13,112],"Some":[14],"lymphomas":[15,75],"are":[16],"resistant":[17,77],"anti-hCD20;":[19],"others":[20],"relapse":[21],"after":[22],"treatment":[23],"with":[24,37,135],"anti-hCD20.":[25],"Using":[26],"syngeneic":[28],"immunocompetent":[29],"mouse":[30],"model,":[31],"we":[32],"observed":[33],"targeting":[35],"lymphoma":[36,44,120],"interferon-\u03b1":[38],"(IFN\u03b1)":[39],"abolished":[40,105],"resistance":[41,108],"of":[42,57,62,93],"anti-CD20":[46,63],"while":[47],"limiting":[48],"interferon":[49],"(IFN)-associated":[50],"systemic":[51],"toxicity":[52],"in":[53,109],"the":[54,85,91],"host.":[55],"Control":[56],"tumors":[58],"by":[59,121],"fusion":[61],"and":[64,133],"IFN\u03b1":[65],"(anti\u2013CD20-IFN\u03b1)":[66],"depended":[67],"on":[68],"existing":[69],"tumor-infiltrating":[70,94,129],"CD8+":[71,95,130],"T":[72,96,131],"cells.":[73],"Although":[74],"were":[76],"IFN-directed":[79],"killing,":[80],"IFN-exposed":[81],"tumor":[82,123],"cells":[83,88,97,124,132],"became":[84],"dominant":[86],"antigen-presenting":[87],"(APC)":[89],"for":[90],"reactivation":[92],"then":[99],"controlled":[100],"those":[101],"lymphomas.":[102],"Anti\u2013CD20-IFN\u03b1":[103],"also":[104],"checkpoint":[106],"blockade":[107],"advanced":[110],"Our":[113],"findings":[114],"indicate":[115],"anti\u2013CD20-IFN\u03b1":[117],"eradicates":[118],"employing":[122],"as":[125],"APCs":[126],"reactivate":[128],"synergizing":[134],"anti\u2013PD-L1":[136],"treatment.":[137],"Cancer":[138],"Immunol":[139],"Res;":[140],"5(7);":[141],"560\u201370.":[142],"\u00a92017":[143],"AACR.":[144]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-04-06T00:00:00"}